What is Global Facial Cosmetic and Plastic Surgery Market?
The Global Facial Cosmetic and Plastic Surgery Market is a vast and rapidly evolving sector that encompasses a wide range of procedures aimed at enhancing the aesthetic appeal of the face. This market includes both surgical and non-surgical treatments, such as facelifts, rhinoplasty, eyelid surgery, brow lifts, and more. The global market is driven by a growing desire for beauty and youthfulness, advancements in surgical techniques, and an increasing acceptance of cosmetic and plastic surgery. In 2023, the market was valued at a substantial US$ 45840 million, and it is projected to skyrocket to US$ 173000 million by 2030, demonstrating a robust CAGR of 20.6% during the forecast period of 2024 to 2030.
Implants, Injectable in the Global Facial Cosmetic and Plastic Surgery Market:
The Global Facial Cosmetic and Plastic Surgery Market is segmented into implants and injectables. Implants are used to alter the structure of the face, such as augmenting the cheekbones or chin, or reshaping the nose. They are made from a variety of materials, including silicone, gore-tex, and medpor. On the other hand, injectables, such as Botox and dermal fillers, are used to reduce wrinkles, add volume, and rejuvenate the skin. The choice between implants and injectables depends on the patient's needs, desired results, and the surgeon's recommendation. The market for these treatments is growing due to the increasing demand for minimally invasive procedures, technological advancements, and the desire for quick results with minimal downtime.
Hospitals, Dermatology Clinics, Beauty Centers, Othes in the Global Facial Cosmetic and Plastic Surgery Market:
The Global Facial Cosmetic and Plastic Surgery Market finds its application in various areas such as hospitals, dermatology clinics, beauty centers, and others. Hospitals are the primary users of these procedures due to the availability of advanced facilities and skilled professionals. Dermatology clinics also offer a range of facial cosmetic and plastic surgeries, often specializing in non-surgical treatments like injectables. Beauty centers, on the other hand, provide more holistic services, combining surgical procedures with other beauty treatments for a comprehensive approach to beauty and wellness. Other areas where these procedures are used include private practices and academic institutions. The usage of these procedures in these areas is driven by factors such as the growing demand for aesthetic treatments, increasing disposable income, and the rising prevalence of skin disorders.
Global Facial Cosmetic and Plastic Surgery Market Outlook:
The future of the Global Facial Cosmetic and Plastic Surgery Market looks promising. In 2023, the market was valued at US$ 45840 million, and it is expected to reach a staggering US$ 173000 million by 2030. This represents a compound annual growth rate (CAGR) of 20.6% during the forecast period from 2024 to 2030. This growth is not isolated, as the global market for medical devices, of which facial cosmetic and plastic surgery devices are a part, is also on an upward trajectory. In 2023, the global medical devices market was estimated to be worth US$ 603 billion, and it is projected to grow at a CAGR of 5% over the next six years. These figures underscore the significant potential and opportunities in the facial cosmetic and plastic surgery market.
| Report Metric | Details |
| Report Name | Facial Cosmetic and Plastic Surgery Market |
| Accounted market size in 2023 | US$ 45840 million |
| Forecasted market size in 2030 | US$ 173000 million |
| CAGR | 20.6% |
| Base Year | 2023 |
| Forecasted years | 2024 - 2030 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | AbbVie, Galderma, LG Life Sciences, Merz, Medytox, HUGEL, Croma-Pharma, Beijing IMEIK, Bloomage Bio, Elravie (Humedix), Cleviel (Pharma Research Products), Haohai Biological, Q.O.Fill (JW Pharmaceutical), Teoxane, Sinclair, Suneva Medical, CG Bio, SciVision Biotech, Prollenium, Matex-Lab, Jingjia Medical, Genoss, Bohus BioTech, Caregen |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
